tgen

(The Translational Genomics Research Institute) Researchers at the Translational Genomics Research Institute today announced a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells.In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of Medicine in St.

Louis discovered that introducing a particular inhibitor drug can turn "off'' receptors responsible for the growth of tumors in a significant number of patients with endometrial cancer.

Clinical researchers at Scottsdale Healthcare and TGen today announced the results of two clinical trials that show promise for patients battling cancer.

The Phase I clinical trial findings, presented at the this weeks Annual Meeting of the American Association for Cancer Research by Daniel Von Hoff, MD, FACG, focused on basal cell carcinoma and pancreatic cancer.